Chronic diseases and disorders are a major burden on society, costing billions of dollars in healthcare costs and lost productivity each year. While there is no single silver bullet for reversing these conditions, cell-based therapies show promise in restoring the biochemical and metabolic processes that are disrupted in disease states. By targeting the cellular pathways that are involved in the progression of chronic diseases, it may be possible to halt or even reverse the progression of these conditions. This approach holds promise not only for improving the quality of life for those affected by chronic disease, but also for reducing the overall economic burden of these conditions.
